Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

6.93
BATS BZX Real-Time Price
As of 10:26am ET
 -0.19 / -2.67%
Today’s Change
5.06
Today|||52-Week Range
11.74
-1.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$111.7M

Company Description

Conatus Pharmaceuticals, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel medicines to treat liver diseases. It develops lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, Steven J. Mento and Charles J. Cashion on July 13, 2005 and is headquartered in San Diego, CA.

Contact Information

Conatus Pharmaceuticals, Inc.
16745 West Bernardo Drive
San Diego California 92127
P:(858) 376-2600
Investor Relations:
(858) 376-2637

Employees

Shareholders

Mutual fund holders9.29%
Other institutional9.03%
Individual stakeholders49.13%

Top Executives

Steven J. MentoPresident, Chief Executive Officer & Director
Charles J. CashionChief Financial Officer, Secretary & SVP-Finance
Alfred P. SpadaCSO, Executive VP-Research & Development
Gary Craig BurgessChief Medical Officer & SVP-Clinical Research
Daniel L. RipleyVP-Business Development & Program Management

To view my watchlist

Not a member yet?

Sign up now for a free account